Investor Relations


Aug 32022 8:30 AM EDT Aug 3, 2022 | 8:30 AM EDT
Regeneron Pharmaceuticals Q2 2022 Earnings Conference Call
Jun 142022 11:40 AM EDT Jun 14, 2022 | 11:40 AM EDT
Goldman Sachs 43rd Annual Global Healthcare Conference
Jun 102022 10:30 AM EDT Jun 10, 2022 | 10:30 AM EDT
2022 Annual Meeting of Shareholders

We are a leading science and technology company that delivers life-transforming medicines for serious diseases.

Founded by physician-scientists more than 30 years ago, our science-driven approach has resulted in nine FDA-approved medicines and numerous product candidates in a range of diseases, including blindness-causing eye diseases, severe inflammatory conditions like asthma and atopic dermatitis, hematologic conditions, pain and infectious diseases such as Ebola and COVID-19.


Analyst Center

Interactive and downloadable financial data for investors and analysts

Contact us

Investor Relations


Media Relations